Brown University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brown University sits in the top decile of US sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count).
Brown University: 231 sponsored US clinical trials, 34 recruiting.
Brown University sponsors 231 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 156 completed. 6 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Drinking, with 8 trials.
Top-decile sponsor footprint
Brown University ranks in the top decile of sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 179 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
231 total, page 1 of 5
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
NCT07663448
Probenecid Administration for Alcohol Craving and Consumption
NCT07118618
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
NCT07398443
The Dynamics of Representational Change Underlying Recall
NCT07442266
Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
NCT06974604
Head and Neck Cancer Study Project in the Geriatric Population
NCT06998069
Systematic Psychophysical
NCT06965478
Promoting Physical Activity and Healthy Eating in Latinas
NCT06979297
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
NCT06555133
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
NCT06948058
Intranasal Insulin for Treatment of Alcohol Use Disorder
NCT05988632
Evaluating an Intervention for Physician Burnout
NCT06969950
Generalization and Specificity of Visual Learning During Sleep
NCT07015840
Teen Health Choices & Wellness
NCT06822569
Investigating The Role of Noise Correlations in Learning
NCT06673303
Intervention to Enhance PrEP Persistence
NCT06872307
Substance Use Prevention for Youth With Parents in Recovery
NCT05397691
Cognitive Control & the Functional Organization of the Frontal Cortex
NCT06436209
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
NCT06099288
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
NCT05839119
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
NCT04092010
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
NCT05754190
Using Family-Based Approaches to Improve Healthy Eating for Southeast Asian Children
NCT05817838
Cannabis' Impact on Alcohol Consumption
NCT05389930
Exercise Incentives for YMCA Based Exercise
NCT05704712
Optimizing PrEP Uptake and Adherence Among Male Sex Workers
NCT05736614
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
NCT04792502
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
NCT05169385
Health Effects of the Standardized Research E-Cigarette in Smokers With HIV Smokers With HIV
NCT03862924
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
NCT04933903
Skills to Enhance Positivity in Suicidal Youth
NCT04994873
Pre-exposure Prophylaxis (PrEP) for Health
NCT04430257
Opioid Treatment and Peer Recovery Support
NCT04978168
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
NCT04135846
Growth, Empowerment, and Mindfulness (GEM): A Mindfulness-based Intervention to Address Mental Health in Young Adults With Early Life Adversity
NCT07546799
Alcohol Feedback, Reflection and Morning Evaluation
NCT05509218
Musical Playlist of the Grief Journey
NCT06445010
Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
NCT05480384
Improving Mental Health Among the LGBTQ+ Community
NCT05540067
Mobile Peer Support for OUD Recovery
NCT05405712
Deliver-EE: Evaluating Effects of Meal Delivery
NCT05357261
Comparing Self-paced Versus Moderate Intensity Physical Activity Recommendation for Midlife Adults
NCT05285748
Veterans Coordinated Community Care (3C) Study
NCT05272176
Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections
NCT04552171
Using Telehealth to Address Alcohol Misuse in HIV Care
NCT04546971
A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
NCT04253262
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
NCT03374332
Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung
NCT03589547
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03355976
Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma
NCT02656706
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 32 |
| Phase 2 | 57 |
| Phase 3 | 4 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the Brown University pipeline
34 recruiting of 231 indexed (15% open); 156 completed (68%).
Phase mix: 6 late (III/IV) vs 89 early (I/II) (early-phase heavy).
Top condition: Alcohol Drinking (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brown University: open-pipeline peers nationwide
Peers matched on 231 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 231 trials (± recruiting share)
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
- University of Iowa · 228 trials · 12% recruiting
- Georgetown University · 227 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Amicus Therapeutics · 15% recruiting · 34 trials
- Loma Linda University · 15% recruiting · 237 trials
- University of Rochester · 15% recruiting · 636 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
Related
What to do with this Brown University page
231 registered trials is a research-attention snapshot, not an endorsement of Brown University or any single study.
- 34 of Brown University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Drinking is the condition Brown University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Drinking trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brown University pipeline card: 231 registered trials from official public datasets.Report a data error.